Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization EBIAT Leases Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Non-Current Receivables Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In Process Receivables - Net Receivables - Other Receivables Refunds Shares Issued Shares Outstanding Shares Outstanding

Summit Therapeutics (SMMT) Shares Issued (2020 - 2025)

Summit Therapeutics' Shares Issued history spans 6 years, with the latest figure at $2.7 million for Q4 2025.

For Q4 2025, Shares Issued fell 93.94% year-over-year to $2.7 million; the TTM value through Dec 2025 reached $82.0 million, down 71.56%, while the annual FY2025 figure was $7.3 million, 1123.24% up from the prior year.
Shares Issued reached $2.7 million in Q4 2025 per SMMT's latest filing, down from $76.8 million in the prior quarter.
In the past five years, Shares Issued ranged from a high of $200.0 million in Q2 2024 to a low of -$104.7 million in Q2 2023.
Average Shares Issued over 5 years is $26.5 million, with a median of $2.7 million recorded in 2025.
Peak YoY movement for Shares Issued: surged 29800.0% in 2021, then crashed 101.54% in 2025.
A 5-year view of Shares Issued shows it stood at $73.1 million in 2021, then plummeted by 100.4% to -$295000.0 in 2022, then skyrocketed by 1496.61% to $4.1 million in 2023, then skyrocketed by 973.37% to $44.2 million in 2024, then tumbled by 93.94% to $2.7 million in 2025.
Per Business Quant, the three most recent readings for SMMT's Shares Issued are $2.7 million (Q4 2025), $76.8 million (Q3 2025), and -$3.1 million (Q2 2025).